<p>Exosome-based vaccines hold significant promise in cancer immunotherapy, yet their native forms face inherent challenges, including imprecise targeting, suboptimal immunogenicity, and poor controllability of antigen loading. This review posits that engineering is pivotal to transforming exosomes from passive carriers into active, programmable therapeutic platforms. We systematically dissect the multifaceted antitumor mechanisms of exosomes and critically evaluate how various engineering strategies (e.g., physical loading, genetic modification, membrane functionalization) are designed to address these specific biological bottlenecks, thereby establishing a coherent “biological limitation–engineering solution” framework. Building on this foundation, we assess their application potential and ongoing challenges in areas such as personalized neoantigen vaccines.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Exosome-based vaccines in cancer immunotherapy: antitumor mechanisms, engineering strategies, and challenges

  • Huanling Zhou,
  • Yuanxin Shi,
  • Yueyue Wang,
  • Guohui Bai

摘要

Exosome-based vaccines hold significant promise in cancer immunotherapy, yet their native forms face inherent challenges, including imprecise targeting, suboptimal immunogenicity, and poor controllability of antigen loading. This review posits that engineering is pivotal to transforming exosomes from passive carriers into active, programmable therapeutic platforms. We systematically dissect the multifaceted antitumor mechanisms of exosomes and critically evaluate how various engineering strategies (e.g., physical loading, genetic modification, membrane functionalization) are designed to address these specific biological bottlenecks, thereby establishing a coherent “biological limitation–engineering solution” framework. Building on this foundation, we assess their application potential and ongoing challenges in areas such as personalized neoantigen vaccines.